TP53 and breast cancer: DMBA-induced mammary tumorigenesis in rats is different from that in human breast cancer in several important aspects: (i) the use of the genotoxic chemical carcinogen and (ii) molecular genetic differences (lack of p53 and BRCA mutations) [39], [40].